SCHEMBL2155246

SCHEMBL2155246

CCOCOc1ccc2c(c1)OCC(CCC(=O)O)(CCC(=O)O)C2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
S1PR5 Q9H228 8/20 0.36
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 2/20 0.36
FFAR1 O14842 3/20 0.34
FFAR4 Q5NUL3 2/20 0.34
MAOB P27338 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
MAOA P21397 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PPARG P37231 3/20 0.34
PPARD Q03181 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2155852 0.84 CYP19A1 (0.43) MAPTFFAR1MAOBALDH1A1HPGD
SCHEMBL2155251 0.83 ALDH1A1 (0.36) TSHRMAPTALDH1A1HPGDKDM4E
SCHEMBL2155276 0.82 MAPT (0.40) TSHRMAPTALDH1A1HPGDKDM4E
SCHEMBL4620365 0.78 MAOB (0.36) MAOBALDH1A1HPGDMAOANPC1
SCHEMBL2156098 0.78 CYP19A1 (0.39) TSHRL3MBTL1MAOBKDM4EGAA
SCHEMBL2156976 0.72 APEX1 (0.44) TSHRL3MBTL1MAOBALDH1A1HPGD
SCHEMBL2155244 0.71 MEN1 (0.43) TSHRMAPTL3MBTL1HPGDKDM4E
SCHEMBL11392871 0.66 CYP19A1 (0.40) MAPTMAOBALDH1A1HPGDKDM4E
SCHEMBL5854508 0.66 CYP19A1 (0.37) MAPTMAOBALDH1A1HPGDMAOA
SCHEMBL2155281 0.66 MAPT (0.42) MAPTALDH1A1KDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US claimed
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US disclosed
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production BCKDK, SYMPK, DHPS TSHR 4824/4885MAPT 3287/4885L3MBTL1 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.